Alto Neuroscience, INC. (ANRO) SEC Filings — 2024
19 SEC filings for Alto Neuroscience, INC. (ANRO) in 2024.
Filings
- Alto Neuroscience, INC. SC 13G Filing — SC 13G · Nov 14, 2024
- Alto Neuroscience, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Alto Neuroscience 10-Q Filing: Q3 2024 Update — 10-Q · Nov 12, 2024
- Alto Neuroscience, INC. SC 13G Filing — SC 13G · Nov 12, 2024
- Alto Neuroscience, INC. SC 13G Filing — SC 13G · Nov 8, 2024
- Alto Neuroscience Files 8-K Report — 8-K · Oct 22, 2024
- Alto Neuroscience, INC. SC 13G Filing — SC 13G · Oct 21, 2024
- Alto Neuroscience Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- Alto Neuroscience Files 8-K: Material Agreement & Equity Sales — 8-K · Jul 29, 2024
- Alto Neuroscience Appoints New Chief Medical Officer — 8-K · May 21, 2024
- Alto Neuroscience Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Alto Neuroscience, INC. SC 13G Filing — SC 13G · Mar 29, 2024
- Alto Neuroscience, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 21, 2024
- Alto Neuroscience Appoints New CMO, Adds Director — 8-K · Mar 11, 2024
- Alpha Wave Global Takes 5.0% Stake in Alto Neuroscience — SC 13G · Feb 9, 2024
- Point72 Asset Management Takes 5.1% Stake in Alto Neuroscience — SC 13G · Feb 7, 2024
- Alto Neuroscience Common Stock Lists on NYSE Under ANRO — 8-K · Feb 6, 2024
- Alto Neuroscience, Inc. Files Amendment No. 1 to S-1 Registration Statement — S-1/A · Jan 29, 2024
- Alto Neuroscience, Inc. Files S-1 Registration Statement — S-1 · Jan 12, 2024